PRLR hFc Chimera, Canine

PRLR hFc Chimera, Canine
Item number Size Datasheet Manual SDS Delivery time Quantity Price
GSC-Z04715-100 100 µg -

Request delivery time estimate

497.00€
GSC-Z04715-500 500 µg -

Request delivery time estimate

1,680.00€
 
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate... more
Product information "PRLR hFc Chimera, Canine"
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers.
Keywords: PRLR, Prolactin receptor
Supplier: GenScript
Supplier-Nr: Z04715

Properties

Conjugate: No
Species reactivity: dog
MW: 53.89 kD
Purity: >95% (Bis-Tris PAGE)

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PRLR hFc Chimera, Canine"
Write a review
or to review a product.
Viewed